FIBRIFACT Trademark

Trademark Overview

On Wednesday, November 19, 2014, a trademark application was filed for FIBRIFACT with the United States Patent and Trademark Office. The USPTO has given the FIBRIFACT trademark a serial number of 79159512. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 19, 2024. This trademark is owned by LABORATOIRE FRANÇAIS; DU FRACTIONNEMENT ET; DES BIOTECHNOLOGIES. The FIBRIFACT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin; injectable pharmaceutical preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin
fibrifact

General Information

Serial Number79159512
Word MarkFIBRIFACT
Filing DateWednesday, November 19, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 19, 2024
Registration Number4824458
Registration DateTuesday, October 6, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin; injectable pharmaceutical preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin
Pseudo MarkFIBRI FACT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANÇAIS; DU FRACTIONNEMENT ET; DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANÇAIS; DU FRACTIONNEMENT ET; DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANÇAIS; DU FRACTIONNEMENT ET; DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, February 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 10, 2015APPLICATION FILING RECEIPT MAILED
Tuesday, March 10, 2015ASSIGNED TO EXAMINER
Wednesday, March 11, 2015NON-FINAL ACTION WRITTEN
Thursday, March 12, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, April 4, 2015REFUSAL PROCESSED BY IB
Tuesday, May 26, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 26, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 5, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, March 12, 2015REFUSAL PROCESSED BY MPU
Thursday, March 12, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 15, 2015ASSIGNED TO LIE
Wednesday, June 17, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, January 6, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 26, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 27, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 16, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, May 11, 2016GENERIC MADRID TRANSACTION CREATED
Wednesday, May 11, 2016GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 22, 2022CANCELLED SECTION 71
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, April 12, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, June 13, 2025DEATH OF INTERNATIONAL REGISTRATION
Friday, June 13, 2025NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, March 14, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, December 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, February 15, 2023GENERIC MADRID TRANSACTION CREATED
Wednesday, February 15, 2023GENERIC MADRID TRANSACTION SENT TO IB

Related Keywords

fibrifact synthetic proteins blood natural transgenic semi pharmaceutical origin namely treatment